AZD9291 : p38α MAP kinase inhibitors to overcome EGFR tertiary C797S point mutation associated with osimertinib in non-small cell lung cancer (NSCLC): emergence of fourth-generation EGFR inhibitor

VX-445 : Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis

3-TYP : Honokiol protects against diabetic retinal microvascular injury via sirtuin 3-mediated mitochondrial fusion